Ascendis Pharma A ASND
NASDAQ ASND
$227.87 +0.56 (+0.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Asset Writedowns and Impairment (2025)

Updated

Ascendis Pharma A's Asset Writedowns and Impairment was -$2.59 million in the quarter ended Dec 31, 2025.

Analysis

Ascendis Pharma A (ASND) Asset Writedowns and Impairment (2025) Analysis & Trends

For the year ended Dec 31, 2025, Asset Writedowns and Impairment at Ascendis Pharma A came in at $5.97 million.

  • In earlier years, Asset Writedowns and Impairment was $8.47 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Ascendis Pharma A 14.12 Bn 10.37 Bn 362.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.59 Mn
Mar 31, 2025 7.90 Mn
API Access

Ascendis Pharma A Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ASND&period=max&api_key=YOUR_API_KEY